Advances in the Diagnosis, Treatment, and Prognosis of Aortic Stenosis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 30 July 2024 | Viewed by 75
Special Issue Editor
Special Issue Information
Dear Colleagues,
Aortic stenosis was first described in 1663 by Lazare Riviere with “ossified” aortic stenosis further delineated by Jean Nicolas Corvisart in the late 18th century.
Aortic stenosis is the most common valvular heart disease diagnosed in Western countries. Patients with a tri-leaflet aortic valve present with calcific aortic stenosis in an older patient population with multiple co-morbidities; however, bicuspid aortic valve disease causes aortic stenosis in a younger population, in which long-term outcomes are especially relevant. Untreated aortic stenosis can progress to heart failure, and subsequent mortality can be high. Unlike other causes of heart failure, no effective medical therapy to prevent or abate aortic stenosis has been identified since it was first described in 1663. As such, aortic valve replacement is the only therapeutic option to impact both the survival and quality of life of these patients. Therefore, it is imperative to identify accurate and innovative methodologies to understand the genetic and acquired etiologies of aortic stenosis. In light of the continually aging population, it is equally as imperative to delineate effective diagnostic and therapeutic strategies to optimize outcomes in all age and economic subpopulations. Models of risk stratification permit timely therapeutic options for both moderate and severe aortic stenosis. This includes clearly defined indications for surgical and transcatheter aortic valve replacement.
The goal of this Special Issue is to highlight novel and innovative approaches to the diagnosis and risk stratification of aortic stenosis to optimize therapeutic strategies including surgical aortic valve replacement (SAVR) and transfemoral aortic valve replacement (TAVR).
Dr. Rita Milewski
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- aortic valve stenosis
- aortic valve replacement
- surgical aortic valve replacement
- transfemoral aortic valve replacement
- risk stratification for aortic stenosis
